Stem Cell-Mediated Angiogenesis in Tissue Engineering Constructs

Author(s): Nasim Kiaie, Rouhollah M. Aghdam*, Seyed H. Ahmadi Tafti, Armita M. Gorabi.

Journal Name: Current Stem Cell Research & Therapy

Volume 14 , Issue 3 , 2019

Become EABM
Become Reviewer

Abstract:

Angiogenesis has always been a concern in the field of tissue engineering. Poor vascularization of engineered constructs is a problem for the clinical success of these structures. Among the various methods employed to induce angiogenesis, stem cells provide a promising tool for the future. The present review aims to present the application of stem cells in the induction of angiogenesis. Additionally, it summarizes recent advancements in stem cell-mediated angiogenesis of different tissue engineering constructs.

Keywords: Angiogenesis, stem cell, tissue engineering, in-vitro, in-situ, hypoxia.

[1]
Novosel EC, Kleinhans C, Kluger PJ. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev 2011; 63(4-5): 300-11.
[2]
Nomi M, Atala A, Coppi PD, Soker S. Principals of neovascularization for tissue engineering. Mol Aspects Med 2002; 23(6): 463-83.
[3]
Laschke MW, Menger MD. Vascularization in tissue engineering: Angiogenesis versus inosculation. Eur Surg Res 2012; 48(2): 85-92.
[4]
des Rieux A, Ucakar B, Mupendwa BP, et al. 3D systems delivering VEGF to promote angiogenesis for tissue engineering. J Control Release 2011; 150(3): 272-8.
[5]
Mao Z, Shi H, Guo R, et al. Enhanced angiogenesis of porous collagen scaffolds by incorporation of TMC/DNA complexes encoding vascular endothelial growth factor. Acta Biomater 2009; 5(8): 2983-94.
[6]
Zhang Z, Buwalda SJ, Dijkstra PJ, et al. Polymeric systems for delivery of growth factors to stimulate angiogenesis in tissue engineering. J Control Release 2008; 132(3): e52-3.
[7]
Singh S, Wu BM, Dunn JC. The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin. Biomaterials 2011; 32(8): 2059-69.
[8]
Cheng CI, Hsiao CC, Wu SC, et al. Valsartan impairs angiogenesis of mesenchymal stem cells through Akt pathway. Int J Cardiol 2013; 167(6): 2765-74.
[9]
Cheung C, Sinha S. Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation. J Mol Cell Cardiol 2011; 51: 651-64.
[10]
Karam JP, Muscari C, Montero-Menei CN. Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium. Biomaterials 2012; 33(23): 5683-95.
[11]
Ye Z, Zhou Y, Cai H, Tan W. Myocardial regeneration: Roles of stem cells and hydrogels. Adv Drug Deliv Rev 2011; 63(8): 688-97.
[12]
Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002; 2: 826-35.
[13]
Ping YF, Bian XW. Consice review: Contribution of cancer stem cells to neovascularization. Stem Cells 2011; 29(6): 888-94.
[14]
Zhao Y, Bao Q, Renner A, Camaj P, et al. Cancer stem cells and angiogenesis. Int J Dev Biol 2011; 55: 477-82.
[15]
Wang C, Lin K, Chang J, Sun J. Osteogenesis and angiogenesis induced by porous beta-CaSiO(3)/PDLGA composite scaffold via activation of AMPK/ERK1/2 and PI3K/Akt pathways. Biomaterials 2013; 34(1): 64-77.
[16]
Szöke K, Brinchmann JE. Concise review: Therapeutic potential of adipose tissue-derived angiogenic cells. Stem Cells Transl Med 2012; 1(9): 658-67.
[17]
Gorabi AM, Tafti SHA, Soleimani M, Panahi Y, Sahebkar A. Cells, scaffolds and their interactions in myocardial tissue regeneration. J Cell Biochem 2017; 118(8): 2454-62.
[18]
Rabbani S, Soleimani M, Imani M, et al. Regenerating heart using a novel compound and human wharton jelly mesenchymal stem cells. Arch Med Res 2017; 48(3): 228-37.
[19]
Rabbani S, Soleimani M, Sahebjam M, et al. Effects of endothelial and mesenchymal stem cells on improving myocardial function in a sheep animal model. J Tehran Heart Cent 2017; 12(2): 65-71.
[20]
Kajbafzadeh AM, Tafti SHA, Khorramirouz R, et al. Evaluating the role of autologous mesenchymal stem cell seeded on decellularized pericardium in the treatment of myocardial infarction: An animal study. Cell Tissue Bank 2017; 18(4): 527-38.
[21]
Naseri MH, Madani H, Tafti SHA, et al. Compare CPM-RMI Trial: Intramyocardial Transplantation of autologous bone marrow-derived CD133+ Cells and MNCs during CABG in patients with recent MI: A phase II/III, multicenter, placebo-controlled, randomized, double-blind clinical Trial. Cell J 2018; 20(2): 267-77.
[22]
Menasché P. Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis 2007; 50: 7-17.
[23]
Murry CE, Field LJ, Menasch P. Cell-based cardiac repair: Reflections at the 10-year point. Circulation 2005; 112: 3174-83.
[24]
Tse HF, Lau CP. Therapeutic angiogenesis with bone marrow-derived stem cells. J Cardiovasc Pharmacol Ther 2007; 12: 89-97.
[25]
Sanz L, Santos-Valle P, Alonso-Camino V, et al. Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels. Microvasc Res 2008; 75(3): 308-14.
[26]
Aghdam RM, Shakhesi S, Najarian S, Mohammadi M, Tafti SHA, Mirzadeh H. Fabrication of a nanofibrous scaffold for the in vitro culture of cardiac progenitor cells for myocardial regeneration. Int J Polym Mater Po 2014; 63(5): 229-39.
[27]
Davis ME, Motion JP, Narmoneva DA, Takahashi T, Hakuno D, Kamm RD. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005; 111: 442-50.
[28]
Hillen F, Griffioen AW. Tumour vascularization: Sprouting angiogenesis and beyond. Cancer Metastasis Rev 2007; 26: 489-502.
[29]
Kerbel RS. Molecular origins of cancer: Tumor angiogenesis. N Engl J Med 2008; 358: 2039-49.
[30]
Folkins C, Shked Y, Man S, et al. Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1. Cancer Res 2009; 69: 7243-51.
[31]
Zhao Y, Dong J, Huang Q. Endothelial cell transdifferentiation of human glioma stem progenitorcells in vitro. Brain Res Bull 2010; 82: 308-12.
[32]
Zhai W, Lu H, Chen L, et al. Silicate bioceramics induce angiogenesis during bone regeneration. Acta Biomater 2012; 8(1): 341-9.
[33]
Liu C, Fan Y, Zhou L, et al. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction. Int J Cardiol 2015; 188: 22-32.
[34]
Tang J, Wang J, Yang J, Kong X, Zheng F, Guo L. Mesenchymal stemcells overexpressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg 2009; 36: 644-50.
[35]
Helmrich U, Marsano A, Melly L, et al. Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification. Tissue Eng Part C Methods 2012; 18(4): 283-92.
[36]
Keeney M, Deveza L, Yang F. Programming stem cells for therapeutic angiogenesis using biodegradable polymeric nanoparticles. JoVE 2013. (79): e50736.
[37]
Park HJ, Yang F, Cho SW. Nonviral delivery of genetic medicine for therapeutic angiogenesis. Adv Drug Deliv Rev 2012; 64(1): 40-52.
[38]
Liu G, Wu S, Bharadwaj S, Soker S, Atala A, Zhang Y. Promoting muscle and nerve regeneration after human urine-derived stem cells expression of vascular endothelial growth factor for potential use in treatment of stress urinary incontinency. J Urol 2011; 185.
[39]
Zhang M, Mal N, Kiedrowski M, et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 2007; 21: 3197-207.
[40]
Elmadbouh I, Haider H, Jiang S, Idris NM, Lu G, Ashraf M. Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 2007; 42: 792-803.
[41]
Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 2005; 46: 1339-50.
[42]
Jo J, Nagaya N, Miyahara Y, et al. Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran. Tissue Eng 2007; 13: 317-22.
[43]
Rasoulianboroujeni M, Kupgan G, Moghadam F, et al. Development of a DNA-liposome complex for gene delivery applications. Mater Sci Eng C 2017; 75: 191-7.
[44]
Yau TM, Kim C, Li G, et al. Enhanced angiogenesis with multimodal cell-based gene therapy. Ann Thorac Surg 2007; 83: 1110-9.
[45]
Wei L, Fraser JL, Lu ZY, Hu X, Yu SP. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis 2012; 46: 635-45.
[46]
Wu C, Zhou Y, Xu M, et al. Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity. Biomaterials 2013; 34(2): 422-33.
[47]
Payne TR, Oshima H, Okada M, et al. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol 2007; 50(17): 1677-84.
[48]
Rasoulianboroujeni M, Kiaie N, Tabatabaei FS, et al. Dual porosity protein-based scaffolds with enhanced cell infiltration and proliferation. Sci Rep 2018; 8(1): 14889.
[49]
Hyun JS, Tran MC, Wong VW, et al. Enhancing stem cell survival in vivo for tissue repair. Biotechnol Adv 2013; 31(5): 736-43.
[50]
Yao X, Liu Y, Gao J, et al. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction. Biomaterials 2015; 60: 130-40.
[51]
Mirabella T, Cilli M, Carlone S, Cancedda R, Gentili C. Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model. Biomaterials 2011; 32(15): 3689-99.
[52]
Yeh YC, Wei HJ, Lee WY, et al. Cellular cardiomyoplasty with human amniotic fluid stem cells: In vitro and in vivo studies. Tissue Eng Part A 2010; 16: 1925-36.
[53]
Maureira P, Marie PY, Yu F, et al. Repairing chronic myocardial infarction with autologous mesenchymal stem cells engineered tissue in rat promotes angiogenesis and limits ventricular remodeling. J Biomed Sci 2012; 19: 93.
[54]
Fiumana E, Pasquinelli G, Foroni L, et al. Localization of mesenchymal stem cells grafted with a hyaluronan-based scaffold in the infarcted heart. J Surg Res 2013; 179(1): e21-9.
[55]
Gaebel R, Ma N, Liu J, et al. Patterning human stem cells and endothelial cells with laser printing for cardiac regeneration. Biomaterials 2011; 32(35): 9218-30.
[56]
Man Y, Wang P, Guo Y, et al. Angiogenic and osteogenic potential of platelet-rich plasma and adipose-derived stem cell laden alginate microspheres. Biomaterials 2012; 33(34): 8802-11.
[57]
Kang Y, Kim S, Fahrenholtz M, Khademhosseini A, Yang Y. Osteogenic and angiogenic potentials of monocultured and co-cultured human-bone-marrow-derived mesenchymal stem cells and human-umbilical-vein endothelial cells on three-dimensional porous beta-tricalcium phosphate scaffold. Acta Biomater 2013; 9(1): 4906-15.
[58]
Park BH, Zhou L, Jang KY, et al. Enhancement of tibial regeneration in a rat model by adipose-derived stromal cells in a PLGA scaffold. Bone 2012; 51(3): 313-23.
[59]
Tasso R, Fais F, Reverberi D, Tortelli F, Cancedda R. The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model. Biomaterials 2012; 31: 2121-9.
[60]
Leotot J, Coquelin L, Bodivit G, et al. Platelet lysate coating on scaffolds directly and indirectly enhances cell migration, improving bone and blood vessel formation. Acta Biomater 2013; 9(5): 6630-40.
[61]
Haycock JW. 3D cell culture: A review of current approaches and techniques. Methods Mol Biol (Clifton, NJ) 2011; 695: 1-15.
[62]
Laschke MW, Schank TE, Scheuer C, et al. Three-dimensional spheroids of adipose-derived mesenchymal stem cells are potent initiators of blood vessel formation in porous polyurethane scaffolds. Acta Biomater 2013; 9(6): 6876-84.
[63]
Park HJ, Jin Y, Shin J, et al. Catechol-functionalized hyaluronic acid hydrogels enhance angiogenesis and osteogenesis of human adipose-derived stem cells in critical tissue defects. Biomacromolecules 2016; 17(6): 1939-48.
[64]
Aguirre A, Planell JA, Engel E. Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis. Biochem Biophys Res Commun 2010; 400: 284-91.
[65]
Finney L, Vogt S, Fukai T, Glesne D. Copper and angiogenesis: Unravelling a relationship key to cancer progression. Clin Exp Pharmacol Physiol 2009; 36(1): 88-94.
[66]
Zhang Z, Ito WD, Hopfner U, et al. The role of single cell derived vascular resident endothelial progenitor cells in the enhancement of vascularization in scaffold-based skin regeneration. Biomaterials 2011; 32(17): 4109-17.
[67]
Markowicz M, Koellensperger E, Neuss S, Steffens GCM, Pallua N. Enhancing the vascularization of three-dimensional scaffolds: New strategies in tissue regeneration and tissue engineering. Topics in Tissue Eng 2005; p. 2.
[68]
Park IS, Chung PS, Ahn JC. Adipose-derived stromal cell cluster with light therapy enhance angiogenesis and skin wound healing in mice. Biochem Biophys Res Commun 2015; 462(3): 171-7.
[69]
Foubert P, Barillas S, Gonzalez AD, et al. Uncultured adipose-derived regenerative cells (ADRCs) seeded in collagen scaffold improves dermal regeneration, enhancing early vascularization and structural organization following thermal burns. Burns 2015; 41(7): 1504-16.
[70]
Carraro A, Buggio M, Gardin C, Tedeschi U, Ferroni L, Zavan PB. Mesenchymal stem cells increase neo-angiogenesis and albumin production in a liver tissue-engineered engraftment. Int J Mol Sci 2016; 17(3): 374.
[71]
Qu C, Mahmood A, Liu XS, et al. The treatment of TBI with human marrow stromal cells impregnated into collagen scaffold: Functional outcome and gene expression profile. Brain Res 2011; 1371: 129-39.
[72]
Liu G, Pareta RA, Wu R, et al. Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors. Biomaterials 2013; 34: 1311-26.
[73]
Yao H, Liu N, Lin MC, Zheng J. Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma. Cancer Lett 2016; 379(2): 213-9.
[74]
Zisch AH. Tissue engineering of angiogenesis with autologous endothelial progenitor cells. Curr Opin Biotechnol 2004; 15: 424-9.
[75]
Anderson JD, Johansson HJ, Graham CS, et al. Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-KappaB signaling. Stem Cells 2016; 34(3): 601-13.
[76]
Matsuda K, Katrina FJ, Woods AA, Choi YS, Morrison WA, Dilley RJ. Adipose-derived mesenchymal stem cells promote angiogenesis and tissue formation for in vivo tissue engineering. Tissue Eng Part A 2013; 19(11-12): 1327-35.
[77]
Zhong Z, Gu H, Peng J, et al. GDNF secreted from adipose-derived stem cells stimulates VEGF-independent angiogenesis. Oncotarget 2016; 7(24): 36829-41.
[78]
Kang T, Jones TM, Naddell C, et al. Adipose-Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA-31. Stem Cells Transl Med 2016; 5(4): 440-50.
[79]
Hilkens P, Fanton Y, Martens W, et al. Pro-angiogenic impact of dental stem cells in vitro and in vivo. Stem Cell Res 2014; 12(3): 778-90.
[80]
Saghiri MA, Asatourian A, Sorenson CM, Sheibani N. Role of angiogenesis in endodontics: contributions of stem cells and proangiogenic and antiangiogenic factors to dental pulp regeneration. J of Endod 2015; 41(6): 797-803.
[81]
Thevenot PT, Nair AM, Shen J, Lotfi P, Ko CY, Tang L. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010; 31(14): 3997-4008.
[82]
Baumann L, Prokoph S, Gabriel C, Freudenberg U, Werner C, Beck-Sickinger AG. A novel, biased-like SDF-1 derivative acts synergistically with starPEG-based heparin hydrogels and improves eEPC migration in vitro. J Control Release 2012; 162(1): 68-75.
[83]
Prokoph S, Chavakis E, Levental KR, et al. Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro angiogenic cells. Biomaterials 2012; 33: 4792-800.
[84]
Chim H, Schantz JT, Whiteman M, Gosain AK. QS444. cell guidance: A new concept for tissue engineering using SDF-1 to induce site directed homing of mesenchymal stem cells. J Surg Res 2008; 144(2): 444.
[85]
Kim JH, Jung Y, Kim BS, Kim SH. Stem cell recruitment and angiogenesis of neuropeptide substance P coupled with self-assembling peptide nanofiber in a mouse hind limb ischemia model. Biomaterials 2013; 34: 1657-68.
[86]
Di Maggio N, Piccinini E, Jaworski M, Trumpp A, Wendt DJ, Martin I. Toward modeling the bone marrow niche usingscaffold-based 3D culture systems. Biomaterials 2011; 32: 321-9.
[87]
Montero RB, Vial X, Nguyen DT, et al. bFGF-containing electrospun gelatin scaffolds with controlled nano-architectural features for directed angiogenesis. Acta Biomater 2012; 8(5): 1778-91.
[88]
Landsberg C, Stenger F, Deutsch A, Gelinsky M, Rosen-Wolff A, Voigt A. Chemotaxis of mesenchymal stem cells within 3D biomimetic scaffolds--a modeling approach. J Biomech 2011; 44(2): 359-64.
[89]
Hwang NS, Varghese S, Elisseeff J. Controlled differentiation of stem cells. Adv Drug Deliv Rev 2008; 60(2): 199-214.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 3
Year: 2019
Page: [249 - 258]
Pages: 10
DOI: 10.2174/1574888X13666181105145144
Price: $58

Article Metrics

PDF: 17
HTML: 2
EPUB: 1